Immune Prophylaxis and Therapy for Human Cytomegalovirus Infection
Human Cytomegalovirus (HCMV) infection is widespread and can result in severe sequelae in susceptible populations. Primary HCMV infection of naïve individuals results in life-long latency characterized by frequent and sporadic reactivations. HCMV infection elicits a robust antibody response, includi...
Main Authors: | Evi B. Struble, Haruhiko Murata, Takashi Komatsu, Dorothy Scott |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/16/8728 |
Similar Items
-
Prophylaxis of Cytomegalovirus Infection in Solid Organ Transplantation, Retrospective Evaluation
by: Albekairy AM, et al.
Published: (2022-06-01) -
Cytomegalovirus DNAemia in kidney transplant
recipients after cessation of standard antiviral
prophylaxis; estimated rate on Thai cases and
implication on efficacy of prophylaxis
by: Won Sriwijitalai, et al.
Published: (2019-05-01) -
Usefulness of valacyclovir prophylaxis for cytomegalovirus infection after anti-thymocyte globulin as rejection therapy
by: Eun Jeong Ko, et al.
Published: (2019-03-01) -
Cytomegalovirus infection in gastrointestinal tract: A case series of three patients and review of literature
by: Piyush Ranjan, et al.
Published: (2015-07-01) -
Cytomegalovirus infection in solid malignancies
by: Amit Kumar Agrawal, et al.
Published: (2020-01-01)